Key Points
Question
How much did clinically significant anxiety and depression increase among US adults during the first year of the COVID-19 pandemic?
Findings
In this survey study of more than 1.4 million respondents in the US Behavioral Risk Factor Surveillance System survey, responses to a screening question calibrated to a 4-item Patient Health Questionnaire score of 6 or greater suggested that aggregate prevalence of clinically significant anxiety and depression increased only modestly overall among US adults in 2020 compared with 2017 to 2019.
Meaning
This modest estimated aggregate increase could mask more substantial increases in key population segments (eg, first responders) and might have become larger in 2021 and 2022.